A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia | MicrobiomeTrials
A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2027-05Est. Completion: 2030-06
Enrollment target: 36 participants
Locations
Shenzhen People's Hospital, Shenzhen, Guangdong, China